Fujifilm makes $200M manufacturing investment while Novartis pours $80M+ into China facility

Fujifilm Corporation is investing $200 million into two of its subsidiaries to expand its cell therapy contract development and manufacturing, the company announced Monday.

The investment will go, in part, toward its new headquarters for Fujifilm Cellular Dynamics, which develops and manufactures human-induced pluripotent stem cells…
Click here to view original post